Blenoxane
(Bleomycin)ApprovedSmall molecule
Bristol-Myers SquibbBleomycin is a chemotherapy drug used to treat certain cancers, including testicular cancer, lymphoma, and squamous cell cancers. It works by damaging cancer cell DNA to stop them from growing.[2] Blenoxane is currently approved and in use across 21 indications[4].[1]
Blenoxane is one of 371 small molecule programs targeting Hemangioma. It is currently in Approved.
21
Indications
63
Total Trials
19
Active Trials
370
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 21 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Blenoxane
Bristol-Myers SquibbApproved
Tecentriq
RochePreclinical
DATROWAY
Daiichi SankyoPreclinical
MS Contin
Merck & Co.Preclinical
Adenocard
AstellasPreclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Zinecard
CChildren's Oncology Group
Preclinical
Feraheme
AAzurity Pharmaceuticals
Preclinical
Sporanox
SSebela Pharmaceuticals Development LLC
Preclinical
Paracetamol
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Lymphoma18 trials
Show 15 more trials
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
Completed·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT00369681·51 enrolled
Chemotherapy4 trials
Show 1 more trial
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
Withdrawn·—·Phase 2·NCT00918593·98 enrolled
Hodgkin's Disease3 trials
Germ Cell Tumor3 trials
Plantar Wart3 trials
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
Unknown status·—·Phase 4·NCT03477448·40 enrolled
Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts
Not yet recruiting·—·N/A·NCT07041749·60 enrolled
A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts
Active, not recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Approved·NCT07197541·200 enrolled
25 more indications
Lymphatic Malformation2 trials
Venous malformation2 trials
Classic Hodgkin Lymphoma2 trials
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
Active, not recruiting·—·Phase 2·NCT03712202·155 enrolled
Glioblastoma Multiforme1 trial
Diffuse Large B-Cell Lymphoma1 trial
Vulvar Cancer1 trial
Brentuximab Vedotin1 trial
Cancer1 trial
Brain Metastases1 trial
Electrochemotherapy as a Palliative Treatment for Brain Metastases
Terminated·—·Phase 1·NCT01322100·1 enrolled
Hodgkins lymphoma1 trial
Hodgkin Lymphoma1 trial
Germ Cell Tumors1 trial
Regulatory
FDA Approval Timeline[5]
Jan 1, 1982
BLENOXANE
NDA NDA050443
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Blenoxane drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Bleomycin. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company